HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hermann Reichenspurner Robert C. Robbins Kwok L. Yun Bruce A. Reitz Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reichenspurner, H. Articles by Reitz, B. A. Search for Related Content PubMed PubMed Citation Articles by Reichenspurner, H. Articles by Reitz, B. A. Related Collections Related Article

Ann Thorac Surg 1996;62:1467-1472
© 1996 The Society of Thoracic Surgeons

---

Original Article: General Thoracic

Stanford Experience With Obliterative Bronchiolitis After Lung and Heart-Lung Transplantation

Departments of Cardiothoracic Surgery and Pathology, Division of Pulmonary Medicine, Stanford University School of Medicine, Stanford, California

Background. Obliterative bronchiolitis (OB) is the main chronic complication after heart-lung (HLTx) and lung transplantation (LTx), limiting the long-term success of both transplant procedures.

Methods. Since 1981, 135 HLTxs and 61 isolated LTxs were performed in 184 patients at Stanford University.

Results. The overall prevalence of OB in patients surviving longer than 3 months postoperatively was 64% after HLTx and 68% after LTx. The actuarial freedom from OB was 72%, 51%, 44%, and 29% at 1, 2, 3, and 5 years, respectively, after HLTx and LTx. An analysis of potential risk factors revealed that the frequency and severity of acute rejection episodes (p < 0.001) and the appearance of lymphocytic bronchiolitis on biopsy (p < 0.05) were significantly associated with the development of OB. With regard to diagnosis of OB, pulmonary function tests show early reductions of the forced expiratory flow between 25% and 75% of the forced vital capacity with subsequent decreases in the forced expiratory volume in 1 second. The sensitivity of transbronchial biopsies has increased to 71% since 1993. Current treatment consists of augmented immunosuppression. Concurrent acute rejection episodes or active OB on biopsy have been treated aggressively with high-dose steroid pulses. Analysis of data from 73 patients with OB after HLTx and LTx revealed actuarial 1-, 3-, 5-, and 10-year survival of 89%, 71%, 44%, and 17% versus 86%, 77%, 63% and 56% in patients without OB (p < 0.05 by log-rank analysis). The main complication and cause of death in patients with OB was superimposed respiratory tract infection, which was treated aggressively.

Conclusions. Early diagnosis of OB using pulmonary function tests or transbronchial biopsy is possible and important, because immediate treatment initiation has led to acceptable survival rates, with nearly 50% of affected patients still alive 5 years after transplantation. Current experimental research on OB suggests that immune injury is the main pathogenetic event of airway obliteration in animal models; rapamycin and leflunomide are new immunosuppressive agents that may have the potential to prevent and treat airway obliteration.

Related Article

Discussion
Ann. Thorac. Surg. 1996 62: 1472-1473. [Extract] [Full Text]

This article has been cited by other articles:

				J. F. McDyer Human and Murine Obliterative Bronchiolitis in Transplant Proceedings of the ATS, January 1, 2007; 4(1): 37 - 43. [Abstract] [Full Text] [PDF]

				I. Al-Githmi, N. Batawil, N. Shigemura, M. Hsin, T. W. lee, G.-W. He, and A. Yim Bronchiolitis obliterans following lung transplantation Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 846 - 851. [Abstract] [Full Text] [PDF]

				G. M. Verleden, L. J. Dupont, A. T. Iacono, B. A. Johnson, and T. E. Corcoran Inhaled cyclosporine in lung transplantation. N. Engl. J. Med., April 20, 2006; 354(16): 1752 - 1753. [Full Text] [PDF]

				S. D. Moffatt-Bruce, J. Karamichalis, R. C. Robbins, R. I. Whyte, J. Theodore, and B. A. Reitz Are Heart-Lung Transplant Recipients Protected From Developing Bronchiolitis Obliterans Syndrome? Ann. Thorac. Surg., January 1, 2006; 81(1): 286 - 291. [Abstract] [Full Text] [PDF]

				B. D. Medoff, E. Seung, J. C. Wain, T. K. Means, G. S.V. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation J. Exp. Med., July 5, 2005; 202(1): 97 - 110. [Abstract] [Full Text] [PDF]

				G. M. Verleden, L. J. Dupont, and D. E. Van Raemdonck Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur. Respir. J., February 1, 2005; 25(2): 221 - 224. [Abstract] [Full Text] [PDF]

				R. M. Kotloff, V. N. Ahya, and S. W. Crawford Pulmonary Complications of Solid Organ and Hematopoietic Stem Cell Transplantation Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 22 - 48. [Abstract] [Full Text] [PDF]

				K. Sarahrudi, M. Estenne, P. Corris, J. Niedermayer, C. Knoop, A. Glanville, C. Chaparro, G. Verleden, M. W. Gerbase, F. Venuta, et al. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1126 - 1132. [Abstract] [Full Text] [PDF]

				T.E. Corcoran, G.C. Smaldone, J.H. Dauber, D.A. Smith, K.R. McCurry, G.J. Burckart, A. Zeevi, B.P. Griffith, and A.T. Iacono Preservation of post-transplant lung function with aerosol cyclosporin Eur. Respir. J., March 1, 2004; 23(3): 378 - 383. [Abstract] [Full Text] [PDF]

				V. A. Starnes, M. E. Bowdish, M. S. Woo, R. G. Barbers, F. A. Schenkel, M. V. Horn, R. Pessotto, E. M. Sievers, C. J. Baker, R. G. Cohen, et al. A decade of living lobar lung transplantation: Recipient outcomes J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 114 - 122. [Abstract] [Full Text] [PDF]

				D. Hadjiliadis, R. D. Davis, and S. M. Palmer Is Transplant Operation Important in Determining Posttransplant Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients? Chest, October 1, 2002; 122(4): 1168 - 1175. [Abstract] [Full Text] [PDF]

				S. M. Fiser, C. G. Tribble, S. M. Long, A. K. Kaza, J. A. Kern, D. R. Jones, M. K. Robbins, and I. L. Kron Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome Ann. Thorac. Surg., April 1, 2002; 73(4): 1041 - 1048. [Abstract] [Full Text] [PDF]

				W. Y. Szeto, A. M. Krasinskas, D. Kreisel, S. H. Popma, and B. R. Rosengard Donor antigen-presenting cells are important in the development of obliterative airway disease J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1070 - 1077. [Abstract] [Full Text] [PDF]

				J. W. K. van den Berg, P. J. van Enckevort, E. M. TenVergert, D. S. Postma, W. van der Bij, and G. H. Koeter Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation Chest, December 1, 2000; 118(6): 1648 - 1652. [Abstract] [Full Text] [PDF]

				E.-S. Lee, M. B. Gotway, G. P. Reddy, J. A. Golden, F. M. Keith, and W. R. Webb Early Bronchiolitis Obliterans Following Lung Transplantation: Accuracy of Expiratory Thin-Section CT for Diagnosis Radiology, August 1, 2000; 216(2): 472 - 477. [Abstract] [Full Text]

				J. A. Belperio, M. D. Burdick, M. P. Keane, Y. Y. Xue, J. P. Lynch III, B. L. Daugherty, S. L. Kunkel, and R. M. Strieter The Role of the CC Chemokine, RANTES, in Acute Lung Allograft Rejection J. Immunol., July 1, 2000; 165(1): 461 - 472. [Abstract] [Full Text] [PDF]

				M. REYNAUD-GAUBERT, P. THOMAS, M. BADIER, P. CAU, R. GIUDICELLI, and P. FUENTES Early Detection of Airway Involvement in Obliterative Bronchiolitis after Lung Transplantation . Functional and Bronchoalveolar Lavage Cell Findings Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1924 - 1929. [Abstract] [Full Text]

				J. W. K. van den BERG, A. GEERTSMA, W. van der BIJ, G. H. KOËTER, W. J. de BOER, D. S. POSTMA, and E. M. ten VERGERT Bronchiolitis Obliterans Syndrome after Lung Transplantation and Health-related Quality of Life Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1937 - 1941. [Abstract] [Full Text]

				J.-M. CHARPIN, M. STERN, D. GRENET, and D. ISRAËL-BIET Insulinlike Growth Factor-1 in Lung Transplants with Obliterative Bronchiolitis Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1991 - 1998. [Abstract] [Full Text]

				J. A. DE ANDRADE, J. P. CROW, L. VIERA, C. BRUCE ALEXANDER, K. RANDALL YOUNG, D. C. MCGIFFIN, G. L. ZORN, S. ZHU, S. MATALON, and R. M. JACKSON Protein Nitration, Metabolites of Reactive Nitrogen Species, and Inflammation in Lung Allografts Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2035 - 2042. [Abstract] [Full Text]

				F. M. Wagner, A. Weber, J.-W. Park, S. Schiemanck, S. M. Tugtekin, V. Gulielmos, and S. Schuler New telemetric system for daily pulmonary function surveillance of lung transplant recipients Ann. Thorac. Surg., December 1, 1999; 68(6): 2033 - 2038. [Abstract] [Full Text] [PDF]

				M. A. Norgaard, C. B. Andersen, and G. Pettersson Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation? Eur. J. Cardiothorac. Surg., September 1, 1999; 14(3): 311 - 318. [Abstract] [Full Text] [PDF]

				S. M. Arcasoy and R. M. Kotloff Lung Transplantation N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091. [Full Text] [PDF]

				N. D. Bridges, T. L. Spray, M. H. Collins, N. E. Bowles, and J. A. Towbin ADENOVIRUS INFECTION IN THE LUNG RESULTS IN GRAFT FAILURE AFTER LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., October 1, 1998; 116(4): 617 - 623. [Abstract] [Full Text] [PDF]

				J. I. Fann, M. K. Wilson, J. Theodore, and B. A. Reitz Combined Heart and Single-Lung Transplantation in Complex Congenital Heart Disease Ann. Thorac. Surg., March 1, 1998; 65(3): 823 - 825. [Abstract] [Full Text]